We've upgraded our system! Please take a moment to reset your AOA password by clicking LOGIN and following the instructions.


A renaissance in the treatment of diabetic kidney disease, hypertension in chronic kidney disease, and beyond

By JOM Staff


Chronic kidney disease (CKD) affects approximately 15% of the US population and is associated with significant cardiovascular morbidity and mortality. The two leading causes of end stage kidney disease are hypertension and diabetes mellitus, both of which are modifiable risk factors. The cornerstones of CKD care include early detection, management of associated risk factors, modification of cardiovascular disease risk, slowing progression of disease, and management of complications including anemia, acid base disturbance, and mineral and bone disorders.